Olanzapine Tablet
Product Images NDC 67877-177

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 67877-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olanzapine Tablets 10 mg 1000 Counts (Olanzapine 10mg 1000)

The text describes a medication called "danzagins USP" in tablet form with a dosage of 10mg per tablet and instructions for storage in a controlled room temperature. It also includes a warning to keep the medication out of reach of children and seek professional help in case of accidental overdose. The medication is dispensed with a medication guide to each patient by a licensed pharmacist and manufactured by Ak Laboratories L, located in India, distributed by Accond Laboratories LLC located in New Jersey.*

FDA Label Image

Olanzapine Tablets 15 mg 7 Counts (Olanzapine 15mg 7)

Olanzapine is a medication available in tablet form.*

FDA Label Image

Olanzapine Tablets 20 mg 30 Counts (Olanzapine 20mg 30)

FDA Label Image

Olanzapine Tablets 2.5 mg 7 Counts (Olanzapine 25mg 7)

Olanzapine is a medication available in tablet form which is approved by the United States Pharmacopeia.*

FDA Label Image

Olanzapine Tablets 5 mg 30 Counts (Olanzapine 5mg 30)

FDA Label Image

Olanzapine Tablets 7.5 mg 100 Counts (Olanzapine 75mg 100)

FDA Label Image

Olanzapine Structure (Olanzapine Str 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.